Urb Boarding Skybites – Mixed Berry (1950 mg Total Cannabinoids)

The 65mg per gummy formula is carefully balanced for a functional 'boarding' (calm, focused, ready-to-engage) experience. D9 THC (5mg) provides mild mood elevation and gentle psychoactivity — the entry dose for perceptible but not overwhelming cannabis effect. CBD (25mg) provides the primary anxiolytic, anti-inflammatory, and grounding foundation. CBG (25mg) contributes focus-supporting, mood-brightening properties that complement the CBD base. CBC (10mg) adds anti-inflammatory and neurogenic properties. Together these create a functional multi-cannabinoid wellness formula that is more comprehensive than any single or dual cannabinoid product.

URB's True-Infused Terpenes is a proprietary terpene infusion process that blends strain-specific terpene profiles into the gummy during manufacturing for authentic flavour fidelity and targeted effect character. Rather than adding generic flavouring, URB uses the same terpene profiles found in the effect-category cannabis strains — myrcene and linalool in Mixed Berry for the hybrid focus profile — creating a terpene-cannabinoid synergy designed to produce consistent, targeted effects rather than just pleasant flavour.

At 5mg D9 per gummy with 25mg CBD moderating the psychoactivity, Boarding Skybites is positioned as a functional, low-intoxication daily supplement. The CBD strongly moderates the 5mg D9's CB1 effect, and at this ratio most adult consumers with any cannabis experience will experience very mild, barely perceptible psychoactivity. CBG and CBC add their own non-psychoactive dimensions. URB specifically positions Boarding Skybites as appropriate for any-time functional use — including morning and professional contexts — due to the low D9 dose within the high non-psychoactive cannabinoid context.